15-Deoxy-Δ12,14-prostaglandin J2-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 342, Issue 3, 2012, Pages 816-826

  Raman, Priyadarshini ^a   Kaplan, Barbara L F ^a   Kaminski, Norbert E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2 GLYCEROL ESTER; 2 ARACHIDONOYLGLYCEROL; 2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; 2 CHLORO 5 NITROBENZANILIDE; CALCIUM ION; CALCIUM IONOPHORE; CIGLITAZONE; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN MDM2; ROSIGLITAZONE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CELL NUCLEUS; CONTROLLED STUDY; DNA BINDING; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM; CELL NUCLEUS; DNA-BINDING PROTEINS; ENDOCANNABINOIDS; FEMALE; GLYCERIDES; GLYCEROL; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; NFATC TRANSCRIPTION FACTORS; PPAR GAMMA; PROMOTER REGIONS, GENETIC; PROSTAGLANDIN D2; PROTO-ONCOGENE PROTEINS C-MDM2; T-LYMPHOCYTES;

EID: 84865176485     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.193003     Document Type: Article

References (29)

1. Badran BM, Wolinsky SM, Burny A, and Willard-Gallo KE (2002) Identification of three NFAT binding motifs in the 5′-upstream region of the human CD3γ gene that differentially bind NFATc1, NFATc2, and NF-κB p50. J Biol Chem 277:47136-47148. (Pubitemid 36159223)
2. Berdyshev EV (2005) Endocannabinoids in Inflammation and Immune Response. CRC Press, Boca Raton, FL.
3. Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, and Padula SJ (2000) The nuclear receptor PPAR γ and immunoregulation: PPAR γ mediates inhibition of helper T cell responses. J Immunol 164:1364-1371. (Pubitemid 30067250)
4. Clipstone NA and Crabtree GR (1992) Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695-697.
5. Crabtree GR and Olson EN (2002) NFAT signaling: choreographing the social lives of cells. Cell 109 (Suppl):S67-S79. (Pubitemid 34457853)
6. Cunard R, Ricote M, DiCampli D, Archer DC, Kahn DA, Glass CK, and Kelly CJ (2002) Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol 168:2795-2802. (Pubitemid 34211658)
7. Feng J, Tamaskovic R, Yang Z, Brazil DP, Merlo A, Hess D, and Hemmings BA (2004) Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation. J Biol Chem 279:35510-35517. (Pubitemid 39100551)
8. Glass CK and Rosenfeld MG (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141. (Pubitemid 30070977)
9. Hauser S, Adelmant G, Sarraf P, Wright HM, Mueller E, and Spiegelman BM (2000) Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation. J Biol Chem 275:18527-18533. (Pubitemid 30414814)
10. Heppner TJ, Bonev AD, Eckman DM, Gomez MF, Petkov GV, and Nelson MT (2005) Novel PPARγ agonists GI 262570, GW 7845, GW 1929, and pioglitazone decrease calcium channel function and myogenic tone in rat mesenteric arteries. Pharmacology 73:15-22. (Pubitemid 39664217)
11. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
12. Kanunfre CC, da Silva Freitas JJ, Pompéia C, Gonçalves de Almeida DC, Cury-Boaventura MF, Verlengia R, and Curi R (2004) Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells. Int Immunopharmacol 4:1171-1185. (Pubitemid 38900854)
13. Klotz L, Dani I, Edenhofer F, Nolden L, Evert B, Paul B, Kolanus W, Klockgether T, Knolle P, and Diehl L (2007) Peroxisome proliferator-activated receptor γ control of dendritic cell function contributes to development of CD4+ T cell anergy. J Immunol 178:2122-2131. (Pubitemid 46233409)
14. Lee M, Yang KH, and Kaminski NE (1995) Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J Pharmacol Exp Ther 275:529-536. (Pubitemid 26025542)
15. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, and Compton DR (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
16. Moraes LA, Spyridon M, Kaiser WJ, Jones CI, Sage T, Atherton RE, and Gibbins JM (2010) Non-genomic effects of PPARγ ligands: inhibition of GPVI-stimulated platelet activation. J Thromb Haemost 8:577-587.
17. Ouyang Y, Hwang SG, Han SH, and Kaminski NE (1998) Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol Pharmacol 53:676-683. (Pubitemid 28196490)
18. 2+ currents by PPAR-γ agonists in cultured hippocampal neurons. J Neurochem 109:1800-1811.
19. Pascual G and Glass CK (2006) Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol Metab 17:321-327. (Pubitemid 44397567)
20. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884.
21. Raman P, Kaplan BL, Thompson JT, Vanden Heuvel JP, and Kaminski NE (2011) 15-Deoxy-Δ12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor γ. Mol Pharmacol 80:201-209.
22. Ricote M, Li AC, Willson TM, Kelly CJ, and Glass CK (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79-82. (Pubitemid 28079218)
23. Rockwell CE, Snider NT, Thompson JT, Vanden Heuvel JP, and Kaminski NE (2006) Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor γ dependently of cannabinoid receptors 1 and 2. Mol Pharmacol 70:101-111.
24. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, and Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
25. Suzuki K, Bose P, Leong-Quong RY, Fujita DJ, and Riabowol K (2010) REAP: A two minute cell fractionation method. BMC Res Notes 3:294.
26. Széles L, Töröcsik D, and Nagy L (2007) PPARγ in immunity and inflammation: cell types and diseases. Biochim Biophys Acta 1771:1014-1030. (Pubitemid 47202035)
27. von Knethen A, Soller M, Tzieply N, Weigert A, Johann AM, Jennewein C, Köhl R, and Brüne B (2007) PPARγ1 attenuates cytosol to membrane translocation of PKCα to desensitize monocytes/macrophages. J Cell Biol 176:681-694. (Pubitemid 46333982)
28. Yang XY, Wang LH, Chen T, Hodge DR, Resau JH, DaSilva L, and Farrar WL (2000) Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor γ (PPARγ) agonists. PPARγ co-association with transcription factor NFAT. J Biol Chem 275:4541-4544. (Pubitemid 30108833)
29. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, and Toker A (2005) Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20:539-550. (Pubitemid 41668639)